These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30393114)

  • 21. Nafamostat mesilate, a serine protease inhibitor, suppresses lipopolysaccharide-induced nitric oxide synthesis and apoptosis in cultured human trophoblasts.
    Nakatsuka M; Asagiri K; Noguchi S; Habara T; Kudo T
    Life Sci; 2000; 67(10):1243-50. PubMed ID: 10954057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nafamostat mesilate, as a treatment for heparin resistance, is not associated with perioperative ischemic stroke in patients undergoing cardiac surgery with cardiopulmonary bypass.
    Kikura M; Tanaka K; Hiraiwa T; Tanaka K
    J Cardiothorac Vasc Anesth; 2012 Apr; 26(2):239-44. PubMed ID: 22019206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination chemotherapy of serine protease inhibitor nafamostat mesilate with oxaliplatin targeting NF-κB activation for pancreatic cancer.
    Gocho T; Uwagawa T; Furukawa K; Haruki K; Fujiwara Y; Iwase R; Misawa T; Ohashi T; Yanaga K
    Cancer Lett; 2013 Jun; 333(1):89-95. PubMed ID: 23348695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of nafamostat mesilate on serum activities of pancreatic enzymes and plasma hormone levels].
    Wakayama S; Suzuki T; Sakai T; Matsuki A
    Masui; 1990 Jun; 39(6):734-40. PubMed ID: 2388392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nafamostat mesilate attenuates neuronal damage in a rat model of transient focal cerebral ischemia through thrombin inhibition.
    Chen T; Wang J; Li C; Zhang W; Zhang L; An L; Pang T; Shi X; Liao H
    Sci Rep; 2014 Jul; 4():5531. PubMed ID: 24985053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nafamostat mesilate for anticoagulation in continuous renal replacement therapy.
    Hwang SD; Hyun YK; Moon SJ; Lee SC; Yoon SY
    Int J Artif Organs; 2013 Mar; 36(3):208-16. PubMed ID: 23404639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative studies of nafamostat mesilate and various serine protease inhibitors in vitro].
    Ino Y; Suzuki K; Sato T; Iwaki M
    Nihon Yakurigaku Zasshi; 1986 Dec; 88(6):449-55. PubMed ID: 2435641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nafamostat mesilate suppresses NF-kappaB activation and NO overproduction in LPS-treated macrophages.
    Noguchi S; Nakatsuka M; Konishi H; Kamada Y; Chekir C; Kudo T
    Int Immunopharmacol; 2003 Sep; 3(9):1335-44. PubMed ID: 12890431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion.
    Su R; Dong L; Li Y; Gao M; Han L; Wunderlich M; Deng X; Li H; Huang Y; Gao L; Li C; Zhao Z; Robinson S; Tan B; Qing Y; Qin X; Prince E; Xie J; Qin H; Li W; Shen C; Sun J; Kulkarni P; Weng H; Huang H; Chen Z; Zhang B; Wu X; Olsen MJ; Müschen M; Marcucci G; Salgia R; Li L; Fathi AT; Li Z; Mulloy JC; Wei M; Horne D; Chen J
    Cancer Cell; 2020 Jul; 38(1):79-96.e11. PubMed ID: 32531268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of nafamostat mesilate and minimal-dose aprotinin on blood-foreign surface interactions in cardiopulmonary bypass.
    Kaminishi Y; Hiramatsu Y; Watanabe Y; Yoshimura Y; Sakakibara Y
    Ann Thorac Surg; 2004 Feb; 77(2):644-50. PubMed ID: 14759453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of nafamostat mesilate on coagulation and fibrinolysis in hepatic resection.
    Shimada M; Matsumata T; Shirabe K; Kamakura T; Taketomi A; Sugimachi K
    J Am Coll Surg; 1994 May; 178(5):498-502. PubMed ID: 8167888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized controlled trial for efficacy of nafamostat mesilate in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Ohuchida J; Chijiiwa K; Imamura N; Nagano M; Hiyoshi M
    Pancreas; 2015 Apr; 44(3):415-21. PubMed ID: 25479585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination treatment using adenovirus vector-mediated tumor necrosis factor-alpha gene transfer and a NF-κB inhibitor for pancreatic cancer in mice.
    Furukawa K; Ohashi T; Haruki K; Fujiwara Y; Iida T; Shiba H; Uwagawa T; Kobayashi H; Yanaga K
    Cancer Lett; 2011 Jul; 306(1):92-8. PubMed ID: 21482023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of potential inhibitors and targeting fat mass and obesity-associated protein causing diabesity through docking and molecular dynamics strategies.
    Kumar SU; Rajan B; Kumar DT; Cathryn RH; Das S; Zayed H; Emmanuel Jebaraj Walter C; Ramanathan G; Priya Doss C G
    J Cell Biochem; 2021 Nov; 122(11):1625-1638. PubMed ID: 34289159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Randomized Comparative Study of 24- and 6-Hour Infusion of Nafamostat Mesilate for the Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Prospective Randomized Comparison Trial.
    Kim SJ; Kang DH; Kim HW; Choi CW; Park SB; Song BJ; Nam HS
    Pancreas; 2016 Sep; 45(8):1179-83. PubMed ID: 27253231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual inhibition of nuclear factor kappa-B and Mdm2 enhance the antitumor effect of radiation therapy for pancreatic cancer.
    Shirai Y; Shiba H; Iwase R; Haruki K; Fujiwara Y; Furukawa K; Uwagawa T; Ohashi T; Yanaga K
    Cancer Lett; 2016 Jan; 370(2):177-84. PubMed ID: 26546875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adsorption of Nafamostat Mesilate on AN69ST Membranes: A Single-Center Retrospective and In Vitro Study.
    Nakamura Y; Hara S; Hatomoto H; Yamasaki S; Nakano T; Miyazaki M; Matsumoto N; Irie Y; Ishikura H
    Ther Apher Dial; 2017 Dec; 21(6):620-627. PubMed ID: 28960755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural basis for inhibition of the fat mass and obesity associated protein (FTO).
    Aik W; Demetriades M; Hamdan MK; Bagg EA; Yeoh KK; Lejeune C; Zhang Z; McDonough MA; Schofield CJ
    J Med Chem; 2013 May; 56(9):3680-8. PubMed ID: 23547775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small-Molecule Inhibitors of the RNA M6A Demethylases FTO Potently Support the Survival of Dopamine Neurons.
    Selberg S; Yu LY; Bondarenko O; Kankuri E; Seli N; Kovaleva V; Herodes K; Saarma M; Karelson M
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effect of nafamostat mesilate on metastasis into the livers of mice and on invasion of the extracellular matrix by cancer cells.
    Kimura T; Fuchimoto S; Iwagaki H; Hizuta A; Orita K
    J Int Med Res; 1992 Aug; 20(4):343-52. PubMed ID: 1511773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.